Xylem Inc. $XYL Shares Purchased by J. Stern & Co. LLP

J. Stern & Co. LLP boosted its holdings in Xylem Inc. (NYSE:XYL) by 12,326.6% in the fourth quarter, HoldingsChannel.com reports. The firm owned 45,448,168 shares of the industrial products company’s stock after acquiring an additional 45,082,435 shares during the period. Xylem accounts for approximately 1.9% of J. Stern & Co. LLP’s investment portfolio, making the stock its 15th biggest holding. J. Stern & Co. LLP owned approximately 0.19% of Xylem worth $6,189,132,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Knuff & Co LLC acquired a new position in Xylem in the third quarter worth $27,000. Wexford Capital LP acquired a new position in Xylem in the third quarter worth $27,000. Commonwealth Retirement Investments LLC acquired a new position in Xylem in the fourth quarter worth $27,000. Ramirez Asset Management Inc. boosted its holdings in Xylem by 100.0% in the third quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock worth $30,000 after purchasing an additional 100 shares during the period. Finally, Board of the Pension Protection Fund acquired a new position in Xylem in the fourth quarter worth $27,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Stock Performance

XYL stock opened at $112.19 on Wednesday. The company has a market capitalization of $26.67 billion, a P/E ratio of 27.91, a PEG ratio of 1.58 and a beta of 1.04. The company has a 50-day simple moving average of $115.39 and a 200 day simple moving average of $126.83. Xylem Inc. has a fifty-two week low of $105.29 and a fifty-two week high of $154.27. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.03. The business had revenue of $2.13 billion during the quarter, compared to the consensus estimate of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The company’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.03 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Sell-side analysts predict that Xylem Inc. will post 5.51 earnings per share for the current fiscal year.

Xylem announced that its Board of Directors has approved a stock repurchase program on Wednesday, February 25th that allows the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization allows the industrial products company to repurchase up to 4.8% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s management believes its shares are undervalued.

Xylem Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Thursday, May 28th will be issued a $0.43 dividend. The ex-dividend date of this dividend is Thursday, May 28th. This represents a $1.72 annualized dividend and a yield of 1.5%. Xylem’s dividend payout ratio is presently 42.79%.

Insider Activity

In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the sale, the chief accounting officer owned 3,605 shares of the company’s stock, valued at $423,443.30. This represents a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Jerome A. Peribere acquired 1,210 shares of Xylem stock in a transaction that occurred on Monday, May 4th. The stock was bought at an average cost of $116.61 per share, with a total value of $141,098.10. Following the acquisition, the director directly owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Corporate insiders own 0.32% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on XYL shares. TD Cowen reaffirmed a “hold” rating on shares of Xylem in a report on Monday, February 23rd. Weiss Ratings downgraded shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, May 8th. Citigroup reduced their price target on shares of Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. Barclays reduced their price target on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a report on Wednesday, April 29th. Finally, UBS Group boosted their price target on shares of Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Seven analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $152.77.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.